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Peripheral nerve injuries (PNIs) may result in cellular and molecular changes in
supraspinal structures possibly involved in neuropathic pain (NPP) maintenance.
Activated glial cells in specific supraspinal subregions may affect the facilitatory role of
descending pathways. Sterile chronic compression injury (sCCI) and complete sciatic
nerve transection (CSNT) in rats were used as NPP models to study the activation
of glial cells in the subregions of periaqueductal gray (PAG) and rostral ventromedial
medulla (RVM). Molecular markers for activated astrocytes (glial fibrillary acidic protein,
GFAP) and microglial cells (OX42) were assessed by quantitative immunohistochemistry
and western blotting. The cellular distribution of CCL2/CCR2 was monitored using
immunofluorescence. sCCI induced both mechanical and thermal hypersensitivity
from day 1 up to 3 weeks post-injury. Unilateral sCCI or CSNT for 3 weeks
induced significant activation of astrocytes bilaterally in both dorsolateral (dlPAG) and
ventrolateral PAG (vlPAG) compared to naïve or sham-operated rats. More extensive
astrocyte activation by CSNT compared to sCCI was induced bilaterally in dlPAG
and ipsilaterally in vlPAG. Significantly more extensive activation of astrocytes was
also found in RVM after CSNT than sCCI. The CD11b immunopositive region,
indicating activated microglial cells, was remarkably larger in dlPAG and vlPAG of
both sides from sCCI- and CSNT-operated rats compared to naïve or sham-operated
controls. No significant differences in microglial activation were detected in dlPAG
or vlPAG after CSNT compared to sCCI. Both nerve injury models induced no
significant differences in microglial activation in the RVM. Neurons and activated
GFAP+ astrocytes displayed CCL2-immunoreaction, while activated OX42+ microglial
cells were CCR2-immunopositive in both PAG and RVM after sCCI and CSNT.
Overall, while CSNT induced robust astrogliosis in both PAG and RVM, microglial
cell activation was similar in the supraspinal structures in both injury nerve models.
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Activated astrocytes in PAG and RVM may sustain facilitation of the descending system
maintaining NPP, while microglial activation may be associated with a reaction to
long-lasting peripheral injury. Microglial activation via CCR2 may be due to neuronal and
astrocytal release of CCL2 in PAG and RVM following injury.
Keywords: activated glial cells, CCL2/CCR2, neuroinflammation, periaqueductal gray, rostral ventromedial
medulla, nerve injury, neuropathic pain model
INTRODUCTION
Peripheral nerve injuries (PNIs) due either to trauma, disease or
surgical intervention, usually result in neuroplastic changes in the
central nervous system (CNS) and pain (Berger et al., 2011). Such
changes include the activation of endogenous glial cells of the
CNS, like microglia (Streit et al., 1999; Hanisch and Kettenmann,
2007; Graeber and Streit, 2010) and astrocytes (Ridet et al.,
1997; Pekny and Nilsson, 2005; Sofroniew and Vinters, 2010;
Anderson et al., 2014; Pekny and Pekna, 2014). The activated
glial cells facilitate pain neurotransmission and induce the central
sensitization of spinal neurons located in the dorsal horn. Briefly,
PNI causes the generation of ectopic discharges in the lesioned
afferent nerve fibers and their neurons (Omana-Zapata et al.,
1997; Woolf and Mannion, 1999; Liu et al., 2000; Schaible, 2007),
triggering an increased release of excitatory neurotransmitters
and neuromodulators onto spinal cord neurons and glial cells.
These changes induce central sensitization, glial cell activation,
and hyperexcitability of nociceptive spinal cord neurons that
consequently increase their discharges through the ascending
pain pathways (Zimmermann, 2001; Schaible, 2007; Latremoliere
and Woolf, 2009; Woolf, 2011; Burnstock, 2016).
The cellular and molecular changes described till now have
been extensively studied mainly in the dorsal horn of the spinal
cord and its circuitry (Vranken, 2009, 2012; Boadas-Vaello
et al., 2016), but much less is known about supraspinal changes
associated with the induction and maintenance of neuropathic
pain (NPP) and the underlying mechanisms. Neuroplastic
processes in the spinal cord facilitate the generation and
conduction of action potentials by the ascending pathways up
to supraspinal structures, contributing to both sensory and pain
behavior alterations. The periaqueductal gray (PAG) and rostral
ventromedial medulla (RVM) are particularly interesting given
their pivotal role in nociceptive modulation (Fields et al., 2006).
The PAG has a columnar functional organization with discrete
ventrolateral PAG (vlPAG) and dorsolateral PAG (dlPAG)
columns that have differences in the antinociceptive effects with
respect to their dependence on opiate mechanisms (Lane et al.,
2004; Lovick and Bandler, 2005; Eidson and Murphy, 2013;
Wilson-Poe et al., 2013) and the spinal projection of sciatic nerve
(Keay et al., 1997).
Pre-clinical studies of nerve injury models demonstrated
glial activation in PAG (Mor et al., 2010; Ni et al., 2016)
and RVM (Wei et al., 2008; Guo et al., 2012) associated with
changes in cytokines/chemokines (Wei et al., 2008; Norman
et al., 2010; Chu et al., 2012; Guo et al., 2012). Moreover, the
chemokine CCL2, also known as monocytes chemoattractant
protein 1 (MCP-1), has been demonstrated to play a critical
role in NPP facilitation via its preferred receptor, CCR2 (Gao
et al., 2009; Jung et al., 2009; Gao and Ji, 2010). It was
demonstrated that PNI increases the release of CCL2 in the
dorsal horn of the spinal cord (Van Steenwinckel et al., 2011;
Clark et al., 2013) triggering the activation of microglial cells
(Zhang and De Koninck, 2006; Thacker et al., 2009). The role
of CCL2 signaling in supraspinal structures involved in pain
modulation has still not been completely elucidated. Reactive
microglia cells may synthesize and secrete more inflammatory
mediators, which elicit increasing excitability of superficial
dorsal horn neurons, and enhance secretion of CCL2 from
spinal astrocytes (Clark et al., 2013). Similar processes may
occur also in both PAG subregions as well as in the RVM
which are involved in the alteration of descending pain
modulation.
Overall, despite the available data regarding neuroplastic
changes in supraspinal structures associated with nervous system
injury-induced pathological pain (Boadas-Vaello et al., 2017), the
cellular and molecular processes occurring in these structures as
a consequence of PNI are not yet fully understood. Particularly,
since distinct subregions of PAG may play different or specific
roles in the descending modulation of pain (McMullan and
Lumb, 2006; Eidson and Murphy, 2013), it is of interest
to investigate whether dlPAG and vlPAG show different
pathophysiological responses after PNI, and whether these
responses appear in parallel with RVM glial activation, and to
do so in distinct PNI models. To this end, the present work was
designed to study glial activation in both PAG nuclei and RVM
after two models of sciatic nerve injury, namely, sterile chronic
constriction injury (sCCI) and complete sciatic nerve transection
(CSNT). Moreover, considering the pivotal role of chemokines in
CNS sensitization and NPPmaintenance, the aim of experiments
was also to explore associated chemokine signaling through
monitoring the expression of CCL2/CCR2 which could be
involved in supraspinal glial cross-talk after sciatic nerve
injury.
MATERIALS AND METHODS
Animals and Surgical Procedures
The experiments were performed in 28 adult male rats
(Wistar, 200–250 g, Anlab, a.s. Brno, Czech Republic). Animals
were kept at 22◦C and maintained on a 12 h light/dark
cycle under specific pathogen-free conditions in the animal
housing facility of the Masaryk University. Sterilized food and
water were available ad libitum. All surgical treatments were
carried out under sterile conditions by the same person in
accordance with the European Convention for the Protection of
Frontiers in Cellular Neuroscience | www.frontiersin.org 2 February 2018 | Volume 12 | Article 40
Dubový et al. Supraspinal Structures after Nerve Injury
Vertebrate Animals Used for Experimental and Other Scientific
Purposes and the protocol was approved by the Animal
Investigation Committee of the Faculty of Medicine, Brno, Czech
Republic.
Animals were anesthetized by intraperitoneal (i.p.) injection
of ketamine (60 mg/kg) and xylazine (7.5 mg/kg) and the right
sciatic nerve was exposed at the level of the mid-thigh by blunt
dissection and separated from adhering tissue just proximal to
its trifurcation. Three ligatures (3-0 Ethicon) were tied around
the nerve with 1 mm spacing to reduce nerve diameter by
approximately one third of its original diameter in the sCCI
group (n = 7).
The right sciatic nerve was transected and the proximal stump
was tightly ligated and turned back to prevent spontaneous
reinnervation in the CSNT group (n = 7). The skin of the
right paws of CSNT group animals was covered with picric acid
solution to prevent autotomy. The right sciatic nerve was only
exposed without any lesion in rats (n = 7) subjected to a sham
operation. Retracted muscles and skin incision were closed with
3-0 silk sutures and the operated rats were left to survive for
3 weeks. Seven intact rats were used as naïve controls.
Behavioral Tests
Behavioral responses to noxious mechanical (paw withdrawal
threshold, PWT) and thermal (paw withdrawal latency, PWL)
stimuli were measured in both ipsi- and contralateral hind
paws by Dynamic plantar esthesiometer and Plantar test (UGO
BASILE), respectively. The location of measurement was in the
glabrous skin of the hind paws in the portion of the dermatome
innervated by the tibial nerve. Rats were first acclimated in
clear Plexiglas boxes for 30 min prior to testing. In the case
of thermal hyperalgesia, withdrawal time was measured and
the intensity radiance was set to a value of 50. The paws were
tested alternately with a 5 min interval between tests. Six PWT
and PWL measurements were taken for each paw during each
test session 1 day before and 1, 3, 7, 14 and 21 days after
operation.
Data for mechanical allodynia and thermal hyperalgesia were
expressed as mean ± SD of PWT in grams and PWL in seconds,
respectively. All behavioral tests were conducted in a blind
manner.
After last behavioral tests at day 21 from operation, animals
were sacrificed with a lethal dose of anesthetic and tissue
samples were removed for immunohistochemical and western
blot analysis.
Immunohistochemical Staining
Three naïve rats and three rats from the sCCI, CSNT and
sham operation groups were deeply anesthetized with a lethal
dose of sodium pentobarbital (70 mg/kg body weight, i.p.) and
perfused transcardially with 500 ml phosphate-buffered saline
(PBS, 10 mM sodium phosphate buffer, pH 7.4, containing
0.15MNaCl) followed by 500ml of Zamboni’s fixative (Zamboni
and Demartin, 1967).
Brainstem tissue between the superior and inferior colliculi
was removed and immersed in Zamboni’s fixative at 4◦C
overnight. The samples were washed in 20% phosphate-buffered
sucrose for 12 h and blocked in Tissue-Tekr OCT compound
(Miles, Elkhart, IN, USA). Serial PAG coronal sections (12 µm)
from the central part of the superior colliculi to the upper
edge of the inferior colliculi corresponding to PAG between
6.72–8.04 mm from the bregma (Paxinos and Watson, 1997)
were cut (Leica 1800 cryostat; Leica Microsystems, Wetzlar,
Germany). In the same brainstem tissue, coronal sections
(12 µm) through the medulla 1 mm from posterior edge
of the inferior colliculi corresponding to RVM between
−10.8 mm and −11.4 mm from the bregma (Paxinos and
Watson, 1997) were also prepared. The sections were collected
on gelatin-coated microscopic slides, air-dried and processed for
immunohistochemical staining.
Increased expression and extent of GFAP and
OX42 immunostaining are widely accepted markers of activated
astrocytes (Pekny and Pekna, 2004) and microglial cells
(Blackbeard et al., 2007), respectively. Therefore, indirect
immunofluorescence staining for GFAP and OX42 was used
to detect activation of astrocytes and microglial cells in PAG
and RVM after sciatic nerve injury. Briefly, the sections
were washed with PBS containing 0.05% Tween 20 (PBS-
TW20) and 1% bovine serum albumin for 10 min, and
then treated with 3% normal donkey serum in PBS-TW20
for 30 min. The sections were incubated with 50 µl of
mouse monoclonal anti-CD11b/c antibody (OX42), rabbit
polyclonal anti-glial fibrillary acidic protein (GFAP) or
rabbit polyclonal anti-CCL2 antibody in a humid chamber
at room temperature (21–23◦C) for 12 h to identify activated
microglial cells, astrocytes or CCL2 expression, respectively.
The immunoreaction was visualized by treatment with FITC-
or TRITC-conjugated, affinity purified, donkey anti-mouse or
anti-rabbit secondary antibodies for 90min at room temperature.
Cell nuclei were stained using Hoechst 33342 (Sigma, St. Louis,
MO, USA) and the sections were mounted in Vectashield
aqueous mounting medium (Vector Laboratories, Burlingame,
CA, USA).
A set of PAG and RVM sections was double immunostained
to detect cell types producing CCL2 or expressing CCR2. The
sections were incubated with rabbit or chicken anti-GFAP
antibody to detect activated astrocytes, with mouse monoclonal
OX42 for co-localization in activated microglial cells and
polyclonal or monoclonal NeuN antibody to identify neurons.
The first incubations were combined with immunostaining
with rabbit polyclonal anti-CCL2 antibody or goat polyclonal
anti-CCR2 antibody. The binding of primary antibodies
were visualized by appropriate FITC-, FITC- or AlexaFluor
647-conjugated secondary antibodies (Table 1).
Control sections were incubated by omitting the primary
antibodies (data not shown). Cell nuclei were stained using
Hoechst 33342 and sections were analyzed using a Nikon Eclipse
NI-E epifluorescence microscope equipped with a Nikon DS-Ri1
camera driven by NIS-Elements software (Nikon, Prague, Czech
Republic).
Image Analysis
At least 12 sections (separated from one another by an interval
of about 80 µm) of PAG or RVM for each animal were selected
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TABLE 1 | List of primary and secondary antibodies used for immunofluorescence detection.
Antibody Source Product Dilution
GFAP pAb Rabbit Dako 1:250
GFAP pAb Chicken Abcam 1:500
OX42 mAb Mouse Serotec 1:50
NeuN pAb Rabbit Millipore 1:500
NeuN mAb Mouse Chemicon 1:500
CCL2 pAb Rabbit Serotec 1:250
CCR2 pAb Goat ThermoFisher 1:100
Anti-chicken pAb Goat Abcam 1:200
Anti-rabbit pAb Donkey Millipore 1:400
Anti-mouse pAb Donkey Millipore 1:400
Anti-mouse pAb Goat Millipore 1:400
pAb, polyclonal antibody; mAb, monoclonal antibody.
for image analysis. Immunopositive area for OX42 or GFAP
was measured using the NIS-elements image analysis system
(Laboratory Imaging Ltd., Prague, Czech Republic). Briefly, the
area of interest (40,000 µm2 for PAG; 70,000 µm2 for RVM)
was placed over the dlPAG and vlPAG) or over RVM and
the GFAP- or OX-42-immunostained structures were detected
by a thresholding technique after subtraction of background.
The boundaries of dlPAG and vlPAG columns were defined
according to the rat PAG map (Paxinos and Watson, 1997) and
other anatomical criteria (Keay and Bandler, 2001). The area of
immunostaining for OX42 or GFAP was related to the area of
interest and expressed as the mean of relative area (%)± SD.
Western Blot Analysis
Naïve, sham-, sCCI- and CSNT-operated rats were used for
western blot analysis (four rats for each group). Rats were
killed with CO2, decapitated and the brainstem was removed.
A 2 mm thick coronal slice of the mesencephalon was rapidly
removed at the position from the central part of the superior
colliculi to the upper edge of the inferior colliculi corresponding
to PAG between 6.72 mm and 8.04 mm from the Bregma
(Paxinos and Watson, 1997). Radial segments corresponding
approximately with ipsilateral and contralateral dlPAG and
vlPAG were dissected under a stereomicroscope (see Figure 2E)
according to the boundaries defined using anatomical criteria
(Keay and Bandler, 2001).
A 2 mm coronal slice was cut though the medulla, 1 mm
from posterior edge of the inferior colliculi corresponding
approximately to 1 mm from the interaural line. This section
corresponds to the RVM between −10.8 mm and −11.4 mm
from the bregma (Paxinos and Watson, 1997). A tissue triangle
was then dissected under a stereomicroscope to isolate the RVM
area, including the nucleus raphe magnus, gigantocellularis,
and gigantocelularis pars alpha (see Figure 3E). The RVM
samples were not divided into ipsi- and contra-lateral sides
because no differences were seen during image analysis
of immunostained sections. Tissue samples were collected,
frozen in liquid nitrogen, and stored at −80◦C until further
processing.
The PAG and RVM tissue samples of individual animals were
homogenized in PBS containing 0.1% Triton X-100 and protease
inhibitors (LaRoche, Switzerland), and centrifuged at 15,000 g
for 20 min at 4◦C. Protein concentration was measured in the
tissue supernatant by Nanodrop ND-1000 (Thermo Scientific)
and normalized to the same levels. Each sample, containing
50 µg of protein, was separated by SDS-polyacrylamide gel
electrophoresis (Wei et al., 2008) and transferred to nitrocellulose
membranes by electroblotting (BioRad).
The membranes were blocked with 1% BSA in PBST (3.2 mM
Na2HPO4, 0.5 mM KH2PO4, 1.3 mM KCl, 135 mM NaCl,
0.05% Tween 20, pH 7.4) for 1 h and incubated with mouse
monoclonal anti-CD11b/c antibody (OX42; 1:50, AbD Serotec,
Kidlington, UK) or rabbit polyclonal anti- GFAP (1:250, Dako,
Glostrup, Denmark) overnight. Blots was washed in PBST and
incubated with peroxidase-conjugated anti-mouse or anti-rabbit
secondary antibodies (Sigma, 1:1000) at room temperature
for 1 h. Equal loading of proteins was confirmed by b-actin
staining. Protein bands were visualized using the ECL detection
kit (Amersham) on an LAS-3000 chemiluminometer reader
(Bouchet Biotech) and analyzed using densitometry image
software. No differences were measured between samples of
naïve and sham-operated rats, therefore, OX42 and GFAP
protein data after normalization to actin were expressed as
fold change relative to sham PAG or RVM, which were
set to 1.
Statistical Analyses
Behavioral data among groups were evaluated using two-way
analysis of variance (ANOVA) with repeated measurements.
One-way ANOVA with Student–Newman–Keuls post hoc test
was used for comparison at each time point and p values
less than 0.05 were considered to be significant. Statistical
differences between data for staining area and western blot
analysis were tested using a Mann-Whitney U-test (p < 0.05).
All statistical analyses were performed using STATISTICA
9.0 software (StatSoft, Inc., Tulsa, OK, USA).
RESULTS
Behavioral Tests
All rats operated on to create sCCI of the sciatic nerve displayed
as signs of NPP, decreased thresholds of mechanical allodynia
(PWT) and withdrawal latencies of thermal hyperalgesia (PWL)
restricted to the hind paws ipsilateral to the nerve ligatures.
Decreased PWT and PWL was induced at day 1 and maintained
throughout the period of survival up to 3 weeks when compared
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FIGURE 1 | Results of behavioral tests in rats operated upon to create unilateral sterile chronic compression injury (sCCI) of the sciatic nerve and sham-operated
rats. Development and maintenance of paw withdrawal threshold (PWT) and paw withdrawal latency (PWL) was measured in the ipsilateral hind paws of
sCCI-operated rats indicating mechanical allodynia and thermal hyperalgesia, respectively. Transient thermal hyperalgesia was measured bilaterally 3 days following
sCCI. Data are expressed as mean ± SD of PWT in grams and PWL in seconds for mechanical allodynia and thermal hyperalgesia, respectively. Symbols below the
curves indicate a statistically significant difference (p < 0.05) compared to sham-operated rats.
with sham- operated rats. Hind paws contralateral to sCCI
did not exhibit statistically significant changes of PWT and
PWL when compared with 1 day before operation or with
hind paws of sham-operated rats (Figure 1). In hind paws
of sham-operated animals, no significant changes in PWT
and PWL data were measured compared to 1 day before
operation. No autotomy was found in animals of the CSNT
group.
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FIGURE 2 | Representative sections through dorsolateral periaqueductal gray (dlPAG) and ventrolateral PAG (vlPAG) of naïve (A), sham- (B), sCCI- (C) and complete
sciatic nerve transection (CSNT)-operated (D) rats immunostained for glial fibrillary acidic protein (GFAP). The figures show a bilateral increase in the area containing
activated GFAP+ astrocytes in both dlPAG and vlPAG after sCCI or CSNT for 3 weeks. Scale bars = 80 µm. (E) Schematic representation of the location of dlPAG
and vlPAG and their sampling for western blot analysis. (F) The top panel shows representative western blot of GFAP protein in PAG of naïve and sham-operated
rats and 3 weeks after sCCI or CSNT. (i) indicates ipsilateral and (c) contralateral segments of dorsolateral (dl) and ventrolateral (vl) PAG. Graph below the blot
illustrates density data obtained from three blots after normalization to actin, expressed as fold-change relative to those of sham-operated rats (set as 1). ∗ Indicates a
statistically significant difference (p < 0.05) compared to the value from sham-operated rats; # indicates a statistically significant difference (p < 0.05) between the
values from ipsilateral and contralateral vlPAG.
Activation of Astrocytes in PAG and RVM
after Chronic Compression Injury
Compared to Complete Transection
Increased immunostaining for GFAP is frequently used to
detect activation of astrocytes following various types of
nervous system injury (Pekny and Pekna, 2004). We found
a significantly larger GFAP+ area corresponding to astrocytes
in vlPAG than dlPAG in both naïve and operated rats.
Sciatic nerve injury by sCCI or CSNT for 3 weeks induced
increased GFAP intensity and a significant enlargement of
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GFAP+ area bilaterally in both dlPAG and vlPAG when
compared to naïve or sham-operated controls. In addition,
CSNT gives rise to a larger GFAP+ area in bilateral dlPAG and
only ipsilateral vlPAG when compared with sCCI. However,
a significantly larger GFAP+ area was seen in vlPAG of
the ipsilateral than the contralateral side (Figures 2A–D,
Table 2).
Sections through RVM prepared from the same rats surviving
for 3 weeks with sCCI or CSNT also displayed an increase
in GFAP intensity and robust enlargement of the GFAP
immunopositive area in comparison to RVM sections of naïve
or sham-operated rats (Figures 3A–D). Similarly to PAG, CSNT
gives rise to a larger GFAP+ area than in the same structures of
animals subjected to sCCI (Table 2).
The increased activation of astrocytes in PAG and RVM
after sCCI and CSNT detected by image analysis of GFAP
immunofluorescence areas was confirmed by western blot
analysis of the GFAP protein (Figures 2F, 3F).
Microglia Activation in PAG and RVM after
Chronic Compression in Comparison to
Transection
Activated microglial cells were identified by increased
immunofluorescence staining for CD11b, detected using
the antibody OX42 and by changes in their shape. Weak
OX42 immunofluorescence and microglial cells with limited
ramification occupied a similar proportion of immunostained
areas in both vlPAG and dlPAG of naïve and sham-operated
animals. The OX42 immunoreactive area indicating activated
microglial cells was remarkably larger in vlPAG and dlPAG of
both sides in PAG sections from sCCI- and CSNT-operated
rats when compared to naïve or sham-operated ones. In
contrast to GFAP+ astrocytes, no significant expansion of the
OX42 immunoreactive area was detected in either dlPAG or
vlPAG after CSNT when compared to sCCI of the sciatic nerve
(Figures 4A–H, Table 3). Besides increased immunostaining
intensity and enlargement of the OX42+ area, microglial
activation was recognized by their changed morphology.
In contrast to only a few processes in sections from naïve
and sham-operated rats, activated microglial cells in PAG
displayed more vigorous ramification along with upregulation
of the constitutively expressed marker OX42 (Figures 4A–H,
insets).
Increased OX42 immunostaining intensity and enlargement
of the immunopositive area compared to RVM sections of naïve
or sham-operated rats was also observed in sections through
RVM prepared from the same brainstems as for OX42 analysis
in PAG. No significant increase in OX42+ areas was found in
RVM after CSNT than sCCI of the sciatic nerve (Figures 5A–D,
Table 3). Activated microglial cells in RVM after both types of
sciatic nerve injury were not only highly ramified but some were
also transformed morphologically to ‘‘bushy’’ type microglia
(Figures 5A–D, insets).
Increased activation of microglial cells in PAG and
RVM after sCCI and CSNT detected by image analysis of
OX42 immunofluorescence areas was confirmed by western blot
analysis of the OX42 protein (Figures 4I, 5E).
Neurons and Activated GFAP+ Astrocytes
Display Immunostaining for CCL2 While
Activated OX42+ Microglial Cells Are
Immunopositive for CCR2 in Both PAG and
RVM after Sciatic Nerve Injury
Sections through PAG from naïve and sham-operated rats
show only weak CCL2 immunofluorescence in the cells present
in the dlPAG and vlPAG columns. However, some cells in
the narrow region at the Sylvian canal (aqueduct) displayed
a higher intensity of CCL2 immunofluorescence than in the
dlPAG and vlPAG area (Figures 6A–D). Sciatic nerve injury
by sCCI and CSNT for 3 weeks induced a bilateral increase
of CCL2 immunofluorescence intensity in cells of vlPAG and
ipsilateral dlPAG, while the cells of contralateral dlPAG showed
an intensity like that of naïve or sham-operated rats. Intense
immunofluorescence intensity of CCL2 was found in the cells
of vlPAG than dlPAG 3 weeks after sciatic nerve injury
(Figures 6E–H). RVM sections of naïve and sham-operated
rats displayed very faint CCL2 immunoreaction, but the
intensity increased in the cells 3 weeks after sCCI or CSNT
(Figures 7A–D).
To reveal the cellular origin of CCL2 protein, one set of
sections were double immunostained for CCL2 and GFAP as
marker of activated astrocytes or NeuN, a molecular marker
of neurons. Double immunostaining showed the location of
CCL2 protein in all GFAP+ astrocytes as well as NeuN+
neurons of PAG and RVM (Figures 7E, 8A–F), while OX42+
microglial cells were free of any CCL2 immunofluorescence
(Figures 7F, 8G–I). The same cellular distribution of increased
immunostaining for CCL2 was observed in PAG and RVM
from animals subjected to both sCCI and CSNT for 3 weeks.
TABLE 2 | Percentage of glial fibrillary acidic protein (GFAP+) area ±SD in rostral ventromedial medulla (RVM) and dorsolateral (dl) and ventrolateral (vl) periaqueductal
gray (PAG) of naïve rats as well as in dlPAG and vlPAG of ipsilateral (ipsi) and contralateral (contra) sides from sham-operated rats and rats with sterile chronic
compression injury (sCCI) and complete sciatic nerve transection (CSNT) for 3 weeks (n = 6 for each group).
Naive Sham sCCI CSNT
ipsi contra ipsi contra ipsi contra
dlPAG 4.3 ± 1.8 5.1 ± 2.6 5.3 ± 2.8 8.6 ± 2.5∗ 7.9 ± 2.3∗ 12.5 ± 1.8∗‡ 11.3 ± 2.4∗‡
vlPAG 10.3 ± 2.2+ 10.8 ± 2.9+ 10.9 ± 2.4+ 17.1 ± 2.2+∗† 13.8 ± 2.8+∗ 23.6 ± 3.5+∗†‡ 15.2 ± 2.8+∗
RVM 3.8 ± 1.0 4.1 ± 1.9 17.5 ± 1.3∗ 20.8 ± 2.1∗‡
+Significant difference (p < 0.05) compared to dlPAG. ∗Significant difference (p < 0.05) compared to Naïve or Sham. †Significant difference (p < 0.05) compared to
contralateral side. ‡Significant difference (p < 0.05) compared to sCCI.
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FIGURE 3 | Representative medullary sections showing rostral ventromedial medulla (RVM) from naïve and sham-operated controls (A,B) and 3 weeks after sCCI or
CSNT (C,D). The pictures illustrate increased intensity and expansion of GFAP immunostaining in RVM after sCCI and CSNT in comparison to RVM from naïve or
sham-operated rat. Scale bars = 90 µm. (E) The drawing illustrates dissection of RVM samples for western blots including the nucleus raphe magnus and
gigantocellularis pars alpha (triangle). (F) The top panel illustrates representative western blot of GFAP protein in RVM of naïve and sham-operated rats and 3 weeks
after sCCI or CSNT. ∗ Indicates a statistically significant difference (p < 0.05) compared to the value from sham-operated rats.
Immunostaining for CCR2, a receptor of CCL2, was observed
only in OX42+ microglial cells of both PAG and RVM
(Figures 8J–L), but no CCR2 immunoreaction was found in
GFAP+ astrocytes.
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FIGURE 4 | Representative sections illustrating OX42 immunofluorescence
staining in dlPAG (A–D) and vlPAG (E–H) of naïve, sham-, sCCI- and
CSNT-operated rats. Insets show the typical morphological types of OX42+
microglial cells from the respective animal groups. Scale bars = 90 µm.
(I) Western blot analysis of OX42 (CD11b/c) protein. The top panel illustrates
representative western blot in PAG of naïve and sham-operated rats and rats
3 weeks after sCCI or CSNT. (i) indicates ipsilateral and (c) contralateral
segments of dorsolateral (dl) and ventrolateral (vl) PAG. Graph below the blot
illustrates density data obtained from three blots after normalization to actin,
expressed as fold-change relative to those of sham-operated rats (set as 1).
∗ Indicates a statistically significant difference (p < 0.05) compared to the value
from sham-operated rats.
DISCUSSION
The supraspinal modulatory system is differentially involved
in descending facilitatory and inhibitory pathways to
influence transmission of nociceptive inputs from the
dorsal horn of the spinal cord to the upper structures of
the CNS (Heinricher et al., 1989; Porreca et al., 2002). A
fine equilibrium between the opposing descending controls
exists under normal conditions. Sensitization may durably
alter this balance in favor of facilitations that consequently
give rise to a NPP state. The RVM and PAG of the brainstem
are the principal (and the best studied) structures of the
endogenous modulatory system that alter spinal dorsal
horn processing of sensory input (Heinricher et al., 2009).
Despite a growing body of evidence indicating a role for
PAG and RVM in descending pain modulation, the precise
underlying cellular and molecular mechanisms involved in
descending facilitation and inhibition of the dorsal horn remain
elusive.
Several animal models based on sciatic nerve injury are
used to investigate NPP mechanisms and test novel analgesics.
The chronic constriction injury of the sciatic nerve is most
frequent model e included transection. The original CCI model
created by four ligatures of chromic gut (4–0) loosely tied
around the sciatic nerve results in inflammatory swelling
with subsequent compression of the nerve (Bennett and Xie,
1988). However, Wallerian degeneration distal to traumatic
nerve injury is considered to be neuroinflammation, and it is
impossible to distinguish between nerve inflammation induced
by chromic gut (Maves et al., 1993; Clatworthy et al., 1995) and
proper inflammatory reactions as a consequence of Wallerian
degeneration (Klusáková and Dubový, 2009). Therefore, we used
sCCI of the sciatic nerve to study NPP and glial activation
induced by traumatic nerve injury when damaged axons are
mixed with spared ones influenced with inflammatory mediators
produced only by Wallerian degeneration (Dubový, 2011). The
CCI model is associated with symptoms of chronic nerve
compression (Bennett and Xie, 1988), while the CSNT model is
rather an experimental model to study neuropathic symptoms,
such as ‘‘anesthesia dolorosa’’, pain with reference to the
area in the absence of any sensory signals (Devor, 1994). In
the present study, we used the CSNT model primarily to
compare glial reactions after total and partial (sCCI) nerve
disconnection.
It is well-known that sensitization of the CNS at different
levels by activation of glial cells can contribute to the
development and/or maintenance of chronic pain states after
a PNI (Suzuki et al., 2004). Most experimental results relating
to the role of glial activation in induction and maintenance
of NPP were observations made in the dorsal horn of the
spinal cord (Blackbeard et al., 2007; Milligan and Watkins,
2009). Less attention has been paid to the activation of
glial cells in supraspinal structures. For example, activated
astrocytes were found in RVM after unilateral CCI of the rat
infraorbital nerve (Wei et al., 2008) and in PAG following
CCI of the sciatic nerve (Mor et al., 2010, 2011). In contrast
to these separate studies in PAG and RVM of different
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TABLE 3 | Percentage of OX-42+ area ±SD in RVM and dorsolateral (dl) and ventrolateral (vl) PAG of naïve rats as well as in dlPAG and vlPAG of ipsilateral (ipsi) and
contralateral (contra) sides from sham-operated rats and rats with sCCI and CSNT for 3 weeks.
Naive Sham sCCI CSNT
ipsi contra ipsi contra ipsi contra
dlPAG 6.9 ± 0.9 7.2 ± 1.5 7.0 ± 1.2 13.1 ± 1.8∗ 12.9 ± 2.6∗ 13.9 ± 2.5∗ 13.2 ± 3.7∗
vlPAG 7.9 ± 2.7 8.3 ± 2.6 8.1 ± 2.9 13.4 ± 2.4∗ 12.3 ± 3.7∗ 13.2 ± 2.4∗ 12.6 ± 2.2∗
RVM 0.7 ± 0.2 0.8 ± 0.2 3.6 ± 1.2∗ 3.4 ± 0.7∗
∗Significant difference (p < 0.05) compared to Naïve or Sham (n = 6 for each group).
FIGURE 5 | Representative medullary sections showing RVM from naïve and sham-operated controls (A,B) and rats with sCCI or CSNT (C,D). The pictures illustrate
increased intensity and enlargement of OX42 immunostaining after sCCI and CSNT when compared to RVM from naïve or sham-operated rats. Insets show the
typical morphological types of OX42+ microglial cells from the respective animal groups. Scale bars = 40 µm. (E) Western blot analysis of OX42 (CD11b/c) protein.
The top panel illustrates representative western blot in RVM of naïve and sham-operated rats and rats 3 weeks after sCCI or CSNT. Graph below the blot illustrates
density data obtained from three blots after normalization to actin, expressed as fold-change relative to those of sham-operated rats (set as 1). ∗ Indicates a
statistically significant difference (p < 0.05) compared to the value from sham-operated rats.
experimental models with varying times of survival, we
used the sCCI and CSNT models for 3 weeks to compare
long-lasting activation of astrocytes and microglial cells in
both RVM and PAG depending on the extent of nerve
injury.
Activation of Glial Cells in Ventrolateral
and Dorsolateral Subregions of PAG
The vlPAG with the spinal projection of sciatic nerve (Keay et al.,
1997) has a significant role in descending control of noxious
afferentation via connections with RVM (Eidson and Murphy,
2013). In addition to descending control, vlPAG columns have
projections to many CNS structures critical for the normal
expression of sleep-wake cycles and social behaviors (Monassi
et al., 2003; Mor et al., 2011). An increased number of GFAP+
astrocytes in vlPAG was mainly detected in a subset of rats
which displayed both NPP and disability following CCI of the
sciatic nerve (Mor et al., 2011). In contrast, dlPAG column
has projections primarily to the dorsolateral pons and the
ventrolateral medulla that are implicated in autonomic control
(Cameron et al., 1995). Moreover, descending control from
dlPAG has different effects on nociceptive reflexes evoked by
activation of C- and A-delta fibers (McMullan and Lumb,
2006).
Sciatic nerve injury by sCCI or CSNT for 3 weeks induced
activation of astrocytes bilaterally in both dlPAG and vlPAG
when compared to naïve or sham-operated control rats.
Significantly more extensive activation of astrocytes was
observed in vlPAG on the ipsilateral than the contralateral
side in both models of unilateral sciatic nerve injury that
can be related with the spinal projection of sciatic nerve
(Keay et al., 1997). In contrast, ipsilateral dlPAG displayed
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FIGURE 6 | Representative sections showing immunofluorescence staining for CCL2 in dlPAG and vlPAG of naïve (A,C), sham- (B,D) and CSNT-operated (E–H)
rats. Weak CCL2 immunofluorescence was observed in the cells of both dlPAG and vlPAG from naïve and sham-operated controls (arrows in A–D). Only some cells
located close to the ependymal layer displayed intense CCL2 immunostaining (broad arrows in A–D). Sciatic nerve injury for 3 weeks induced increased
CCL2 immunofluorescence intensity in the cells (arrows) mainly in vlPAG of both ipsilateral (vlPAGi) and contralateral (vlPAGc) sides (G,H). Sections through dlPAG of
the same animal (E,F) displayed distinct CCL2 immunofluorescence in a larger number of cells close to the ependymal layer (broad arrows) compared to naïve and
sham-operated animals. Scale bars = 80 µm.
a more extensive activation of astrocytes when compared
to the contralateral column but this change was not
significant. Our results also revealed a higher induction of
astroglial activation in PAG columns by CSNT than sCCI
indicating a dependence on the extent of the sciatic nerve
injury.
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FIGURE 7 | (A–D) Representative medullary sections showing RVM from naïve (A) and sham-operated (B) controls as well as rats 3 weeks from sCCI (C) or CSNT
(D) after immunostaining for CCL2. Compared to RVM of naïve and sham-operated rats (A,B), CCL2 immunofluorescence intensity was significantly increased in
cells (arrows) of RVM from rats with injured sciatic nerve (C,D). (E,F) Representative pictures of double immunofluorescence for GFAP or OX42 and CCL2 in RVM
after sCCI of the sciatic nerve for 3 weeks. (E) The section was double immunostained for GFAP (red) and CCL2 (green). The merged picture shows expression of
CCL2 protein in all GFAP+ astrocytes of RVM; nuclei (blue) were stained with Hoechst. (F) The section was double immunostained for OX42 (green) and CCL2 (red).
The merged picture shows the absence of CCL2 protein in OX42+ microglial cells (arrows); nuclei (blue) were stained with Hoechst. Scale bars = 90 µm in (B,E);
40 µm in (A,C,D,F).
In contrast to astrocytes, activation of microglial cells was
similar in dlPAG and vlPAG of both sides in the sCCI and CSNT
models of the sciatic nerve injury. This suggests that signaling
leading to microglial activation is maintained bilaterally in both
PAG columns 3 weeks after different types of sciatic nerve injury
(sCCI and CSNT).
Taken together, these findings of activated astrocytes and
microglial cells in vlPAG after sciatic nerve injury suggest
a role for activated glial cells in the modulation of activity
of this PAG column with respect to descending inhibition
or facilitation of nociceptive input following nerve injury (Ni
et al., 2016). It is clinically important that vlPAG and its
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FIGURE 8 | Double immunofluorescence staining in vlPAG of rats 3 weeks from sCCI. (A–F) Sections illustrating double immunofluorescence staining for CCL2 and
GFAP or NeuN as markers of activated astrocytes or neurons, respectively. The merged pictures (C,F) show CCL2 protein in activated astrocytes (arrows) and
neurons (arrowheads). (G–L) Double immunofluorescence staining for OX42 as a marker for microglial cells and CCL2 (G–I) or CCR2 (J–L). The merged picture (I)
shows the absence of CCL2 protein in microglial cells. Compare CCL2 positive astrocyte-like cells (arrows) with the absence of CCL2 immunoreaction in microglial
cells (arrowheads). However, OX42+ microglial cells displayed CCR2 immunostaining (arrowheads in L). Scale bars = 40 µm for (A–F); 75 µm for (G–I); 15 µm for
(J–L).
descending projections to RVM comprise a neural circuit
for opioid-mediated analgesia (Lane et al., 2004; Eidson and
Murphy, 2013; Wilson-Poe et al., 2013). Increased activation of
microglial cells and astrocytes in vlPAG was observed only in
those animals made tolerant to morphine (Eidson and Murphy,
2013).
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Unilateral sciatic nerve injury (sCCI and CSNT) induced
bilateral activation of astrocytes and microglial cells in both
dlPAG and vlPAG. These results are probably related with the
bilateral projections from the spinal cord to PAG responses of
which appear to be predominantly bilateral and non-somatotopic
(Yezierski and Mendez, 1991; Jones et al., 2003).
Activation of Glial Cells in RVM
The RVM provides the major common output of descending
modulatory system that is critical in the maintenance of chronic
pain states (Pertovaara et al., 1996; Porreca et al., 2002; Dubner
and Ren, 2004; Gebhart, 2004; Vanegas and Schaible, 2004;
Vera-Portocarrero et al., 2006; Bee and Dickenson, 2007). The
RVM is a relay in the pathways from both vlPAG and dlPAG
columns (Hudson and Lumb, 1996) with an important dlPAG
connection involved in the modulation of endocannabinoid
stress analgesia (Suplita et al., 2005). Early (1 and 3 days)
and transient activation of microglia and prolonged reaction
of astrocytes (14 days) were found in RVM in relation to
long-lasting mechanical hyperalgesia after CCI of the rat
infraorbital nerve (Wei et al., 2008). In contrast, a bilateral
increase of astrocyte activation was demonstrated after 3 days
with a decrease by day 10 following spinal nerve ligation
(SNL). Conversely, although a weak immunofluorescence was
observed at day 3, markedly stronger OX42 immunostaining
was found at day 10 in rats operated on SNL (Leong et al.,
2011). In our experiments, both types of sciatic nerve injury
induced a strong activation of astrocytes and microglial cells
in RVM, but no differences were found between the astrocyte-
and the microglial activation induced by sCCI and CSNT.
The results indicated that the intensity of glial activation
in RVM after long–lasting nerve injury was not related to
the extent of axotomy; this is consistent with the status of
the RVM as a common output of descending modulatory
system.
Retrograde neuronal death can be assumed as the initial signal
for activation of glial cells after PNI (Flügel et al., 2001), but
we did not investigate neuronal loss of RVM neurons in our
experimental animals in relation to glial activation. However,
there is some controversy about neuronal loss in RVM in
different NPP models. While neuronal loss was found in RVM
following spinal nerve ligature (Leong et al., 2011), it was absent
after CCI or spared nerve injury (SNI) of the sciatic nerve (Leong
et al., 2016). Therefore, other mechanisms of glial activation
should be considered. Since CCL2 has a pivotal role in microglial
cell activation in the dorsal horn after PNI (Zhang and De
Koninck, 2006; Thacker et al., 2009; Van Steenwinckel et al.,
2011; Clark et al., 2013), it is worth exploring the critical role
of this chemokine also on supraspinal glial cross-talk which may
exert NPP facilitation after sciatic nerve injury.
Expression of CCL2 and CCR2 in Activated
Glial Cells of PAG and RVM
Activated glial cells upregulate synthesis and secretion of
numerous cytokines and chemokines that are involved in the
exchange of signals between neurons and the glial cells of CNS
structures. It was also demonstrated that these inflammatory
mediators modulate nociceptive transmission and may influence
NPP induction (DeLeo et al., 1996; Coyle, 1998; Colburn et al.,
1999; DeLeo and Yezierski, 2001; Watkins et al., 2003).
Several lines of evidence suggest that CCL2 and its receptor
CCR2 are expressed in both neurons and glial cells in the dorsal
horn of the spinal cord in animal NPP models (White et al.,
2005; Dansereau et al., 2008; Abbadie et al., 2009; Jung et al.,
2009). CCL2 was detected in primary sensory neurons and
their afferents in the dorsal horn of the spinal cord (Tanaka
et al., 2004; Dansereau et al., 2008; Jeon et al., 2009). Besides
primary afferents, CCL2 protein was also found in GFAP+
astrocytes activated by SNL (Gao et al., 2009). In contrast,
immunohistochemical staining localized the CCR2 protein in
spinal microglia after partial sciatic nerve injury (Abbadie et al.,
2003), whereas the CCR2 mRNA signal was also present in
deep dorsal horn neurons 3 days after SNL (Gao et al., 2009).
Upregulation of CCL2/CCR2 in the spinal dorsal horn of
NPP models suggests an important role for signaling through
this chemokine in the modulation of chronic pain induction
(reviewed in White et al., 2007; Gosselin et al., 2008; White
and Miller, 2010). This was also confirmed by attenuation of
behavioral signs of NPP in CCR2 knock-out mice (Abbadie et al.,
2003).
With respect to surpraspinal structures, neuronal CCL2 and
its receptor CCR2 associated with microglia were selectively
upregulated in the RVM following SNL. Furthermore, injection
of CCL2 into the RVM induced a dose-dependent hyperalgesia
that was prevented by pretreatment with the CCL2 inhibitor
RS-102895 (Guo et al., 2012). This showed that increased levels
of CCL2 in RVM are related with descending facilitation of NPP.
However, the precise cellular distribution of CCL2/CCR2 in PAG
following PNI still remains unclear.
Our results revealed that neurons and activated astrocytes
in both PAG and RVM displayed immunostaining for
CCL2 protein, while activated microglial cells expressed
CCR2 after chronic sciatic nerve injury. The results presented
here and previously published studies of the cellular distribution
of CCL2 and CCR2 suggest that CCL2/CCR2 signaling is
involved in the neuron-glia and glia-glia interactions in both
PAG and RVM after long-lasting nerve injury related to
persistent pain. Based on the observed earlier activation of
microglia, i.e., preceding astrocyte activation (Zhang and De
Koninck, 2006; Hu et al., 2007), we can assume that the injury-
associated nociceptive inputs trigger neuronal responses in PAG
and RVM. Among these responses is the release of neuronal
CCL2 that binds to CCR2 of microglia and promotes their
activation (Zhang and De Koninck, 2006). Activated microglia
may further stimulate astroglial activation through IL-18 and
increase neuronal activity via CXCL1 (Abbadie et al., 2009; Gao
and Ji, 2010). Furthermore, activated astrocytes may contribute
to increased levels of CCL2 resulting in the augmentation of
descending pain facilitation (Guo et al., 2012).
CONCLUSION
Partial sciatic nerve injury by sCCI results in early and more
distinct mechanical and thermal hypersensitivity up to 3 weeks.
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While CSNT induced a robust activation of astrocytes in
both PAG and RVM, the activation of microglial cells was
similar in these supraspinal structures after both types of
sciatic nerve injury. This suggests that activated astrocytes in
PAG and RVM may sustain the facilitation of the descending
system to maintain NPP states, while activation of microglial
cells may be associated with the reaction to long-lasting
PNI. Furthermore, CCL2/CCR2 signaling may be involved in
the neuron-glia and glia-glia interactions in both PAG and
RVM after either sCCI or CSNT, triggering persistent NPP
after PNI.
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